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Engineering a Promiscuous Tautomerase into a More
Efficient Aldolase for Self-Condensations of Linear
Aliphatic Aldehydes
Mehran Rahimi+,[a] Jan-Ytzen van der Meer+,[a] Edzard M. Geertsema,[a, b] and
Gerrit J. Poelarends*[a]
Introduction
The enzyme 4-oxalocrotonate tautomerase (4-OT) is composed
of six identical subunits of only 62 amino acid residues each. It
is a member of the tautomerase superfamily, a group of ho-
mologous proteins having a b-a-b structural fold and a catalytic
amino-terminal proline (Pro1).[1–3] 4-OT takes part in a catabolic
pathway for aromatic hydrocarbons in Pseudomonas putida
mt-2, where it catalyzes the conversion of 2-hydroxyhexa-2,4-
dienedioate (1, Scheme 1) into 2-oxohexa-3-enedioate (2).[4, 5] In
this tautomerization reaction, Pro1 acts as a general base (pKa
&6.4) in abstracting the 2-hydroxy proton of 1 and transferring
it to the C5-position to give 2.[6]
In addition to its natural tautomerase activity, 4-OT promis-
cuously catalyzes several carbon–carbon bond-forming reac-
tions.[7a,8–16] These include various types of aldol reactions such
as the self-condensation of propanal (3 ; Scheme 2), the cross-
condensation of acetaldehyde (6) with benzaldehyde (12), the
cross-coupling of propanal (3) and benzaldehyde (12), and the
intramolecular cyclization of hexanedial (15) or heptane-
dial.[10,12, 16] For the self-condensation of 3, as well as the cross-
condensation of 6 and 12, 4-OT catalyzes both the initial aldol
coupling step to yield the b-hydroxyaldehyde intermediate
and the subsequent dehydration step to yield the final a,b-
unsaturated aldehyde.[12,16] In the proposed mechanism for the
aldolase activity of 4-OT, the active-site Pro1 residue functions
as a nucleophile rather than as a base, and reacts with the car-
bonyl functionality of the aldehyde to form a covalent enam-
ine intermediate.[10,17] This intermediate reacts with another al-
dehyde in an inter- or intramolecular aldol addition, after
which the final product (the aldol compound or the corre-
sponding dehydrated compound) is released from the active
site upon hydrolysis.
Enzyme promiscuity has great promise as a source of syn-
thetically useful catalytic transformations,[2, 7] and can be ex-
ploited as a starting point to create new biocatalysts for chal-
The enzyme 4-oxalocrotonate tautomerase (4-OT) from Pseudo-
monas putida mt-2 takes part in a catabolic pathway for aro-
matic hydrocarbons, where it catalyzes the conversion of 2-
hydroxyhexa-2,4-dienedioate into 2-oxohexa-3-enedioate. This
tautomerase can also promiscuously catalyze carbon–carbon
bond-forming reactions, including various types of aldol reac-
tions, by using its amino-terminal proline as a key catalytic resi-
due. Here, we used systematic mutagenesis to identify two
hotspots in 4-OT (Met45 and Phe50) at which single mutations
give marked improvements in aldolase activity for the self-con-
densation of propanal. Activity screening of a focused library
in which these two hotspots were varied led to the discovery
of a 4-OT variant (M45Y/F50V) with strongly enhanced aldolase
activity in the self-condensation of linear aliphatic aldehydes,
such as acetaldehyde, propanal, and butanal, to yield a,b-un-
saturated aldehydes. With both propanal and benzaldehyde,
this double mutant, unlike the previously constructed single
mutant F50A, mainly catalyzes the self-condensation of propa-
nal rather than the cross-condensation of propanal and benzal-
dehyde, thus indicating that it indeed has altered substrate
specificity. This variant could serve as a template to create new
biocatalysts that lack dehydration activity and possess further
enhanced aldolase activity, thus enabling the efficient enzy-
matic self-coupling of aliphatic aldehydes.
Scheme 1. Proton-transfer reaction naturally catalyzed by 4-OT.
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lenging aldol reactions.[18,19] Previously, we constructed several
active-site mutants of 4-OT, including variant F50A, which had
improved aldolase activity for the cross-condensation of 6 with
12.[12,20] Here, we report the engineering of 4-OT into a more
efficient aldolase for the self-condensation of linear aliphatic
aldehydes such as acetaldehyde (6), propanal (3), and butanal
(9 ; Scheme 2). For this, a large collection of single mutants of
4-OT was screened for mutations that give a strong improve-
ment in the desired aldolase activity; then, identified “hotspot”
positions were subjected to combinatorial mutagenesis.
Results and Discussion
We applied a systematic mutagenesis strategy to identify resi-
due positions at which mutations give a marked improvement
in the aldolase activity of 4-OT. For this, a collection of 1040
single mutants of 4-OT was used (at least 15 of the 19 possible
variants at each residue position, from Ile2 to Arg62).[21] Pro1
mutants were not included in the collection, because Pro1 is
a key catalytic residue and mutations lead to incorrect deme-
thionylation of the protein.[22] The collection was screened for
activity for the self-condensation of 3 under conditions that
allow the detection of variants with strongly improved aldolase
activity only (heatmap in Figure 1).
Two residue positions at which single mutations led to large
improvements in aldolase activity were identified. The first was
Met45: replacement with Thr, His, or Ile resulted in a pro-
nounced improvement. The second was Phe50: substitution
by Val strongly improved aldolase activity. In addition, replace-
ment of His6 with Met and of Ala33 with Lys significantly im-
proved aldolase activity. Mutant F50V showed the highest al-
dolase activity among all variants. Progress curves of the aldol
self-condensation of 3 (50 mm) catalyzed by purified enzymes
confirmed the enhanced activity of mutant F50V compared to
wild-type 4-OT or the previously constructed mutant F50A[12]
(Figure 2).
In order to further improve the aldolase activity of 4-OT, we
constructed a double-site library where the two hotspots,
Met45 and Phe50, were simultaneously randomized by using
NNK-codon degeneracy (N=A/C/G/T, K=G/T),[23,24] to cover all
20 possible amino acids, for both positions. We also construct-
ed a triple-site library in which His6, Met45, and Phe50 were
randomized: NNK-codon degeneracy was used for His6 and
Met45, whereas Phe50 was randomized by using NYK-codon
degeneracy (Y= C/T).[23,24] NYK degeneracy was chosen be-
cause it reduces the library size by covering only the codons of
nine different aliphatic and polar amino acid residues, includ-
ing those residues that result in enhanced aldolase activity, as
well as the wild-type residue. The two libraries were trans-
formed into Escherichia coli BL21(DE3) cells. Approximately 800
transformants from the double-site library and about 3500
from the triple-site library were screened for the aldol self-con-
densation of 3.
Screening of the double-site library identified M45Y/F50V
with strongly enhanced aldolase activity (~30-fold improve-
ment over wild-type) ; the triple-site library did not yield
a mutant with higher activity than that of M45Y/F50V. The
progress curves of the aldol self-condensation of 3 (50 mm)
confirmed the enhanced activity of M45Y/F50V compared to
the single mutants F50V and F50A (Figure 2 and Figure S1 in
the Supporting Information). 1H NMR spectroscopy confirmed
the formation of 5 as the product of the aldol self-condensa-
tion of 3 catalyzed by mutant M45Y/F50V (Figure S2). Hence,
4-OT can be engineered into a more efficient aldolase for the
self-condensation of 3 to yield 5 by exploring small libraries in
which only hotspots are varied.
Scheme 2. Examples of aldol reactions promiscuously catalyzed by 4-OT.
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Next, we tested whether mutant M45Y/F50V also has en-
hanced aldolase activity towards the self-condensation of alde-
hydes 6 and 9. Wild-type 4-OT and mutants of 4-OT (P1A,
F50A, and M45Y/F50V; 150 mm each) were incubated with
either 6 or 9 (50 mm each), and the reactions were monitored
by UV spectroscopy. The results indicate that the self-conden-
sation of 6 or 9 (to give 8 or 11) is enzyme-catalyzed, with var-
iant M45Y/F50V having the strongest activity (Figures 3 and 4).
1H NMR spectroscopy revealed the formation of 7 and 8 as
products of the enzyme-catalyzed self-condensation of 6 (Fig-
ures S3 and S4), and the formation of 11 as a product of the
enzyme-catalyzed self-condensation of 9 (Figures S5 and S6).
Next, we compared the ability of mutants F50A and M45Y/
F50V to catalyze an aldol cross-condensation reaction by using
3 and 12 as substrates. Mutants (150 mm) were incubated with
3 (50 mm) and 12 (2 mm), and the reactions were followed by
UV spectroscopy. The UV spectra of the reaction mixture incu-
bated with mutant F50A showed a decrease in absorbance at
250 nm (Figure 5A), thus indicating the depletion of 12 as the
result of a cross-coupling reaction. Interestingly, the UV spectra
for mutant M45Y/F50V showed a negligible decrease in ab-
sorbance at 250 nm (Figure 5B). Instead, an increase in absorb-
ance at 234 nm was observed (corresponding to the formation
of 5) as the result of the self-condensation of 3. 1H NMR spec-
troscopic analysis confirmed that 13 and 14 were the main
products in the reaction with F50A (indicative of cross-cou-
pling), whereas 5 was the main product for M45Y/F50V (Fig-
ure S7). Hence, compared to the previously constructed
mutant F50A,[12] mutant M45Y/F50V has altered substrate spe-
cificity and prefers the self-condensation of 3 over the cross-
coupling of 3 and 12. This is fully consistent with the fact that
mutant M45Y/F50V was engineered for enhanced activity to-
wards the self-condensation of 3.
In conclusion, we demonstrate that the promiscuous
enzyme 4-OT can be engineered into a more efficient aldolase
(variant M45Y/F50V) for self-condensations of aliphatic alde-
hydes by exploring small libraries in which only two hotspots
(Met45 and Phe50) are varied. Notably, in our recent study, the
Figure 1. Heatmap of aldolase activity of single mutants of 4-OT for the self-condensation of propanal (3). A) The horizontal axis of the data matrix corre-
sponds to the sequence of 4-OT, and the vertical axis depicts the 20 possible amino acid residues. Wild-type residues are indicated by bold squares. White
boxes represent mutants that were not present in the collection; gray boxes represent mutants which were not produced above the detection limit
(0.5 mgmL@1 in the CFE) ; boxes with a crosshatch indicate mutants that precipitated under the screening conditions, thus preventing activity measurements.
The ability of each mutant to catalyze the self-condensation of 3 was monitored by UV-spectroscopy, by following the formation of 5 (lmax=234 nm). B) The
secondary-structure elements of 4-OT.
Figure 2. UV traces for the formation of 5 during the self-condensation of 3
catalyzed by wild-type 4-OT (low activity), or mutants F50A, F50V, or M45Y/
F50V.
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same positions were identified as hotspots for improving the
aldolase activity of 4-OT for the cross-condensation of alde-
hydes 6 and 12 : variant M45T/F50A was identified after muta-
genesis and activity screening.[20] Hence, 4-OT can be tailored
to catalyze a specific aldol reaction. Work is in progress to
determine the crystal structures of 4-OT variant M45Y/F50V in
complex with 5, 8, or 11. Such enzyme–product structures
could guide the design of variants that completely lack dehy-
dration activity and possess further enhanced aldolase activity,
thus enabling the efficient enzymatic self-coupling of small ali-
phatic aldehydes. With only a few natural aldolases available
to catalyze the self-coupling of aldehydes, including 2-deoxy-
ribose-5-phosphate aldolase (DERA)[18b] and d-fructose-6-phos-
phate aldolase (FSA),[19b] the engineering of a promiscuous
enzyme might prove to be a useful approach to create new
biocatalysts for these challenging aldolizations.
Figure 3. UV spectra recorded after incubation of 6 with A) no enzyme (control), B) mutant P1A, C) wild-type 4-OT, D) mutant F50A. and E) mutant M45Y/
F50V. The formation of 8 (lmax=227 nm) was monitored.
Figure 4. UV spectra recorded after incubation of 9 with A) no enzyme (control), B) mutant P1A, C) wild-type 4-OT, D) mutant F50A, and E) mutant M45Y/
F50V. The formation of 11 (lmax=240 nm) was monitored.
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Experimental Section
Materials: The sources for the buffers, solvents, components of ly-
sogeny broth (LB) medium as well as the materials, enzymes and
reagents exploited in molecular biology procedures are reported
elsewhere.[25]
General methods: Standard molecular biology techniques were
performed as previously described.[26] Protein in CFEs and purified
samples was analyzed by PAGE by using pre-casted NuPAGE 10%
polyacrylamide gels (Novex; 10% Bis·Tris). Coomassie brilliant blue
was used to stain the gels. Protein concentrations were deter-
mined by the Waddell method.[27] Enzymatic assays were per-
formed in a V-650 or V-660 spectrophotometer (Jasco) or with
a SPECTROstar Omega plate reader (BMG LABTECH). 1H NMR spec-
tra were recorded on a Varian Inova 500 spectrometer (500 MHz)
with a pulse sequence for selective presaturation of the water
signal. Chemical shifts for protons are reported in ppm and are ref-
erenced to H2O (d=4.80 ppm).
Expression and purification of wild-type 4-OT and 4-OT mutants:
Wild-type 4-OT and 4-OT mutants were produced in E. coli
BL21(DE3) as native proteins without an affinity tag, from either
a pET20b(+) or pJexpress 414[21] expression vector. The construc-
tion of the expression vectors for wild-type 4-OT and 4-OT mutants
P1A and F50A, as well as the purification procedure for 4-OT, were
reported previously.[10,12]
Cell-free extract (CFE) preparation of E. coli cells expressing the
single 4-OT mutants: A defined collection of 1040 single mutant
4-OT genes, each cloned into pJexpress 414, was purchased from
DNA2.0 (ATUM, Newark, CA). The mutant vectors were transformed
into E. coli BL21 (DE3), as described elsewhere,[21] and stored at
@80 8C. Expression of the mutant 4-OT genes in E. coli BL21(DE3),
the preparation of CFEs, and the assessment of concentrations of
the mutants are described elsewhere.[21]
Determination of the aldolase activity: The aldolase activity in
CFE was determined by UV spectroscopy in UV-star mclear 96-wells
microtiter plates (MTP; Greiner Bio-one). The reaction mixtures con-
sisted of CFE (30% v/v) and propanal (3, 40 mm) in NaH2PO4 buffer
(100 mL, 10 mm, pH 7.3). MTPs were sealed with VIEWseal UV-trans-
parent seals (Greiner Bio-one) to prevent evaporation, and incubat-
ed for 16 h at 25 8C, with the reaction progress monitored by UV
spectroscopy (220–500 nm). Formation of product 5 (lmax=
234 nm) was quantified based on the increase in absorbance at
234 nm. In order to eliminate false positives as a result of protein
precipitation (in this case there is an increase in absorbance over
the whole UV spectrum), reaction mixtures in which there was
a high increase in absorbance at 350 nm (DA350>0.5) were as-
signed as “precipitation’’ (Figure 1). At this wavelength product 5
has no UV absorbance. The aldolase activity of wild-type 4-OT was
used as a reference, and mutants with a marked improvement in
aldolase activity were identified. The heat map (Figure 1) was pre-
pared in Microsoft Excel 2010; the data are represented as colors
for visual interpretation.
Construction of double- and triple-mutant libraries: The con-
struction of the double and triple mutant libraries is described
elsewhere.[20]
UV spectroscopic assay for the self-condensation of 3: The self-
condensation of propanal (3) at RT was monitored for 20 h by
following the increase in absorbance at 234 nm; this corresponds
to the formation of 2-methylpent-2-enal (5). Enzyme (150 mm) was
incubated in a 1 mm cuvette with 3 (50 mm) in NaH2PO4 buffer
(0.3 mL, 20 mm, pH 7.3). UV spectra were recorded from 200–
400 nm (Figures S1 and 2).
Redissolving WT 4-OT and 4-OT mutants in NaD2PO4 buffer: A VI-
VASPIN concentrator (5000 Da cut-off; Sartorius, Goettingen, Ger-
many) was washed four times with H2O by centrifugation (1900g,
20 min). Subsequently, the concentrator was charged with enzyme
(300 mL, ~10 mgmL@1 in NaH2PO4 buffer (20 mm, pH 7.3)) and cen-
trifuged (1900g, 30 min). The enzyme was retained on the filter
then redissolved in NaD2PO4 (200 mL, 20 mm ; pD 7.6) and centri-
fuged (1900g, 30 min). The remaining enzyme on the filter was
redissolved in NaD2PO4 (300 mL, 20 mm ; pD 7.6), and the final
enzyme concentration was determined. Exchange of NaH2PO4 with
NaD2PO4 was carried out only for enzyme preparations for the
1H NMR spectroscopic assay for the self-condensation of 3 or cross-
coupling of 3 and 12.
1H NMR spectroscopic assay for the self-condensation of 3:
Enzyme (290 mm) was incubated with 3 (30 mm) at RT in NaD2PO4
buffer (650 mL, 20 mm ; pD 7.6) in an NMR tube, with [18]crown-6
ether as the internal standard (2.15 mm). A control sample was pre-
pared containing all components except enzyme. 1H NMR spectra
were recorded at about 1 h after the start of the incubation, and
subsequently after 1, 4, 8, and 14 days.
Compound 3: 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6): d=9.69
(t, J=1.3 Hz, 1H), 2.57 (dq, J=7.3, 1.3 Hz, 2H), 1.06 ppm (t, J=
7.3 Hz, 3H).
Hydrated form of 3: 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6):
d=4.96 (t, J=5.5 Hz, 1H), 1.59 (dq, J=7.5, 5.5 Hz, 2H), 0.92 ppm (t,
J=7.5 Hz, 3H).
Compound 5: 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6): d=9.29
(s, 1H), 6.81 (t, J=7.6 Hz, 1H), 2.41 (dq, J=7.6, 7.6 Hz, 2H), 1.71 (s,
3H), 1.09 ppm (t, J=7.6 Hz, 3H).
Internal standard [18]crown-6 (1,4,7,10,13,16-hexaoxacyclooctade-
cane): 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6): d=3.68 ppm (s,
24H).
UV spectroscopic assay for the self-condensation of 6: The self-
condensation of 6 was monitored for 20 h at RT by following the
increase in absorbance at 227 nm (formation of 8). Enzyme
(150 mm) was incubated in a 1 mm cuvette with 6 (50 mm) in
NaH2PO4 buffer (0.3 mL, 20 mm pH 7.3). UV spectra were recorded
from 200–400 nm (Figure 3).
1H NMR spectroscopic assay for the self-condensation of 6:
Enzyme (290 mm, in NaH2PO4 (20 mm)) was incubated with 6
(50 mm) at RT in NaD2PO4 buffer (650 mL, 20 mm ; pD 7.6) in an
NMR tube, with [18]crown-6 ether as the internal standard
(2.15 mm). A control sample was prepared containing all compo-
nents except enzyme. 1H NMR spectra were recorded approximate-
Figure 5. UV spectra recorded after incubation of 3 and 12 with mutants
A) F50A and B) M45Y/F50V.
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ly 2 h after the start of the incubation and then after 1, 4, and 7
days.
Compound 6: 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6): d=9.66
(q, J=3.0 Hz, 1H), 2.23 ppm (d, J=3.0 Hz, 3H).
Hydrated form of 6 : 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6):
d=5.23 (q, J=5.3 Hz, 1H), 1.32 ppm (d, J=5.3 Hz, 3H).
Compound 7: 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6): d=9.69
(t, J=5.9 Hz, 1H), 5.16 (m, 1H), 2.03 (m, 2H), 1.18 ppm (d, J=
5.9 Hz, 3H).
Compound 8: 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6): d=9.37
(d, J=8.3 Hz, 1H), 7.19 (m, 1H), 6.21 (m, 1H), 2.05 ppm (d, J=
7.0 Hz, 3H).
UV spectroscopic assay for the self-condensation of 9: The self-
condensation of 9 was monitored for 20 h at RT by following the
increase in absorbance at 240 nm (formation of 11). Enzyme
(150 mm) was incubated in a 1 mm cuvette with 9 (50 mm) in
NaH2PO4 buffer (0.3 mL, 20 mm, pH 7.3). UV spectra were recorded
from 200–400 nm (Figure 4A–E).
1H NMR spectroscopic assay for the self-condensation of 9:
Enzyme (290 mm in NaH2PO4 (20 mm)) was incubated with 9
(50 mm) at RT in NaD2PO4 buffer (650 mL, 20 mm, pD 7.6) in an
NMR tube, with [18]-crown-6 ether as the internal standard
(2.15 mm). A control sample was prepared containing all compo-
nents except enzyme. 1H NMR spectra were recorded approximate-
ly 2 h after the start of the incubation and then after 1, 4, and 7
days.
Compound 9: 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6): d=
9.65–9.67 (m, 1H), 2.50 (m, 2H), 1.59–1.67 (m, 2H), 0.88–0.94 ppm
(m, 3H).
Hydrated form of 9: 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6):
d=5.03 (t, J=5.5 Hz, 1H), 1.31–1.43 (m, 2H), 1.53–1.59 (m, 2H),
0.88–0.94 ppm (m, 3H).
Compound 11: 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6):
1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6): d=9.26 (s, 1H), 6.75
(t, J=7.5 Hz, 1H), 2.42 (q, J=7.3 Hz, 2H), 2.25 (m, 2H), 1.55 (m,
2H), 0.90–0.97 (m, 3H), 0.90–0.97 ppm (m, 3H).
UV spectroscopic assay for the cross-coupling of 3 and 12: The
cross-coupling of 3 and 12 was monitored for 5 h at RT by follow-
ing the decrease in absorbance at 250 nm (depletion of 12) and
the increase in absorbance at 234 nm (formation of 5). Enzyme
(150 mm) was incubated in a 1 mm cuvette with 3 (50 mm) and 12
(2 mm) in NaH2PO4 buffer (0.3 mL, 20 mm, pH 7.3). UV spectra were
recorded from 200–400 nm (Figure 5).
1H NMR spectroscopic assay for the cross-coupling of 3 and 12:
Enzyme (290 mm) was incubated with 3 (30 mm) and 6 (15 mm) in
NaD2PO4 buffer (650 mL, 20 mm, pD 7.6) in an NMR tube, with [18]-
crown-6 ether as internal standard (2.15 mm). A control sample
was prepared with all the components except enzyme. 1H NMR
spectra were recorded approximately 2 h after the start of the in-
cubation, and then after 1, 4, 8, and 14 days.
Compound 12: 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6): d=
9.94 (s, 1H), 7.97 (d, J=7.9 Hz, 2H), 7.76 (d, J=7.5 Hz, 1H),
7.63 ppm (dd, J=7.9, 7.5 Hz, 2H).
Compound 13: 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6): d=
9.74 (s, 1H), 7.48–7.36 (m, 5H), 5.23 (s, 1H), 1.03 ppm (s, 3H).
Hydrated form of 13: 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6):
d=7.48–7.36 (m, 5H), 5.21 (s, 1H), 4.94 (s, 1H), 0.94 ppm (s, 3H).
Compound 14: 1H NMR (500 MHz, 20 mm NaD2PO4 ; pD 7.6): d=
9.49 (s, 1H), 7.67 (d, J=7.5 Hz, 2H), 7.55–7.50 (m, 4H), 2.03 ppm (s,
3H).
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